Translational Development Acquisition Corp

Translational Development Acquisition Corp(TDAC)股票分析

$10.840

-0.005 (-0.05%)收盤時

Loading chart…
High
10.850
Open
10.850
VWAP
10.84
Vol
10.28K
Mkt Cap
Low
10.820
Amount
111.42K
EV/EBITDA, TTM
0.00

Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.

AI analysis of Translational Development Acquisition Corp (TDAC)

hold

Translational Development Acquisition Corp (TDAC) is currently at a price of 10.84, with a recent 5-day change of -0.05% and a year-to-date change of +3.83%. The RSI is at 51.89, indicating a neutral momentum. While the merger with ProLogium could provide growth potential, the forward P/E ratio is 0, suggesting uncertainty in future earnings. The main risk is the negative net income reported in Q3 2024 at -61283.00 USD, which raises concerns about profitability.

估值指標

The current forward P/E ratio for Translational Development Acquisition Corp (TDAC) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
高估
0.00
低估
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
高估
0.00
低估
0.00

Forward P/S

Fair
5Y Average P/S
0.12
Current P/S
0.00
高估
1.22
低估
-0.98

Alphio AI Price Scenarios for TDAC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%TDAC

$9.29

情境價格

B

Base

Base · 50%TDAC

$9.21

情境價格

B

Bear

Bear · 25%TDAC

$8.24

情境價格

TDAC FAQ — answered by Alphio AI

Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.

Translational Development Acquisition Corp (TDAC) is currently at a price of 10.84, with a recent 5-day change of -0.05% and a year-to-date change of +3.83%. The RSI is at 51.89, indicating a neutral momentum. While the merger with ProLogium could provide growth potential, the forward P/E ratio is 0, suggesting uncertainty in future earnings. The main risk is the negative net income reported in Q3 2024 at -61283.00 USD, which raises concerns about profitability.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始